Topic: Exclusivity clauses

Dutch court upholds Coca-Cola bottler probe closure

A Rotterdam court has confirmed that the Dutch antitrust watchdog was entitled to drop an abuse of dominance investigation into a Coca-Cola bottler after finding a full probe would be costly and out of line with the agency’s priorities.

02 August 2021

Italy accepts Telecom Italia and DAZN broadcasting commitments

Pay-TV provider DAZN has agreed to open access to its sports streaming content to non-Telecom Italia subscribers to resolve competition concerns related to a football broadcasting agreement, Italy’s Competition Authority has said.

28 July 2021

South African enforcer allowed to pursue supermarket for subsidiary's abuse of dominance

South Africa’s highest court has refused to allow Shoprite Checkers to appeal against an appellate court decision finding the retailer can be held liable for its subsidiary ticket seller’s allegedly abusive exclusivity requirements.

26 July 2021

UK’s electric car charging study jumpstarts antitrust probe

The UK’s antitrust enforcer is investigating exclusivity agreements between an electric vehicle charging provider and three major UK service station operators, after a market study found a lack of chargepoints may prevent drivers from switching to electric cars.

23 July 2021

Pakistan launches dominance probe into Foodpanda

The Competition Commission of Pakistan has launched an investigation into whether Delivery Hero subsidiary Foodpanda abused its dominance in the market for online food delivery - marking the agency's first abuse probe into a digital platform.

08 July 2021

Mexico fines Praxair €9.8 million for breaching commitments

Mexico’s antitrust authority has fined Praxair’s Mexican subsidiary €9.8 million for repeatedly failing to comply with commitments to restore competition in the markets for the bulk distribution of oxygen, nitrogen and liquid argon.

02 June 2021

Taiwan hits cancer drug companies with fines

Taiwan’s competition authority has fined a pair of pharmaceutical companies more than €8 million for entering into an anticompetitive agreement for the exclusive distribution of colorectal cancer drugs.

13 May 2021

Get unlimited access to all Global Competition Review content